RenovoRx to Present at the 43rd Annual Canaccord Genuity Growth Conference

RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced that its CEO Shaun Bagai will provide a corporate overview and update at the...

Related Keywords

Massachusetts ,United States ,Boston ,Shaun Bagai ,World Congress On Gastrointestinal Cancer ,Twitter ,Renovorx Inc ,Company Nasdaq ,Tiger Pac Data Monitoring Committee ,Strategic Communications ,Linkedin ,Annual Canaccord Genuity Growth Conference ,Trans Arterial Micro Perfusion ,Gastrointestinal Cancer ,R Pac Data Monitoring Committee ,Markets ,